Drug Pipeline

Suvorexant Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
6
Recruiting
1
Phase 3
7
Top Sponsors
Active Studies by Phase
Phase 4
2
Phase 3
1
Phase 2
1
Phase 1/2
1
Early Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06584942 Evaluation of Suvorexant for Reduction of Brain Reactivity in Patients With Cannabis Use… Cue-reactivity Recruiting
NCT06788522 The Effects of Orexin Antagonism on Fear Extinction in PTSD Insomnia Not Yet Recruiting
Phase 3
NCT06655883 A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants… Insomnia Recruiting
Phase 2
NCT05546554 Trial of Suvorexant for Sleep in Children With Autism Autism Recruiting
Phase 1/2
NCT06484075 Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms Healthy Volunteers Recruiting
Early Phase 1
NCT06326684 Suvorexant and Alcohol Alcohol Use Disorder Recruiting
Not specified
NCT05630781 Orexin s Role in the Neurobiology of Substance Use Disorder Nicotine Dependence Recruiting
Sponsors Running Suvorexant Trials
Stanford University (1) National Institute on Drug Abuse (NIDA) (1) William Stoops (1) National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) Massachusetts General Hospital (1) Merck Sharp & Dohme LLC (1) VA Office of Research and Development (1)
Disease Areas
PTSD (1)
Get alerts when Suvorexant trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free